Maximus (MMS) Projected to Post Earnings on Thursday

Maximus (NYSE:MMS) is anticipated to post its Q2 2026 results before the market opens on Thursday, May 7th. Analysts expect Maximus to post earnings of $2.03 per share and revenue of $1.3529 billion for the quarter. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Individuals may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, May 7, 2026 at 9:00 AM ET.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the prior year, the business posted $1.61 EPS. The firm’s revenue was down 4.1% compared to the same quarter last year. On average, analysts expect Maximus to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Maximus Stock Up 1.6%

Shares of MMS traded up $1.04 on Tuesday, reaching $65.58. The company’s stock had a trading volume of 178,982 shares, compared to its average volume of 700,414. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus has a twelve month low of $60.75 and a twelve month high of $100.00. The stock has a market capitalization of $3.58 billion, a PE ratio of 9.97 and a beta of 0.60. The firm has a fifty day moving average of $69.28 and a 200-day moving average of $80.41.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, May 15th. Maximus’s dividend payout ratio is currently 20.09%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Weiss Ratings downgraded shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Finally, Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus currently has an average rating of “Hold”.

Insider Activity

In related news, CEO Bruce Caswell bought 3,175 shares of Maximus stock in a transaction dated Tuesday, February 10th. The stock was purchased at an average cost of $78.45 per share, with a total value of $249,078.75. Following the transaction, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at approximately $25,732,619.85. The trade was a 0.98% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jan Madsen sold 742 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director directly owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This represents a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.80% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Sivia Capital Partners LLC bought a new position in shares of Maximus during the 2nd quarter valued at approximately $204,000. Cibc World Markets Corp bought a new position in shares of Maximus during the 4th quarter valued at approximately $323,000. Nebula Research & Development LLC bought a new position in Maximus in the 2nd quarter worth approximately $312,000. Weiss Asset Management LP bought a new position in Maximus in the 4th quarter worth approximately $259,000. Finally, Principal Securities Inc. boosted its holdings in Maximus by 445.6% in the 4th quarter. Principal Securities Inc. now owns 2,575 shares of the health services provider’s stock worth $222,000 after buying an additional 2,103 shares during the period. 97.21% of the stock is owned by institutional investors.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.